drugset / Trial / NCT03005223

Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20163 in Healthy Volunteers

NCT03005223 ↗

Phase 1 Unknown 52 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open label, crossover study to explore drug-drug interactions between DWC20155 / DWC20156 and DWC20163 in Healthy Volunteers

Timeline

Start
2017-01-04
Primary completion
2017-05
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject DWC20155 Unknown — —
Subject DWC20156 Unknown — —
Subject DWC20163 Unknown — —

Indications

No indication recorded.